ArticleScientific reports2025
Evaluation of urinary metabolites as biomarkers for occupational p-chloronitrobenzene exposure: a pilot study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We explored the feasibility of using urinary metabolites of p-chloronitrobenzene (p-CNB) as exposure biomarkers of occupational p-CNB exposure. Forty-two workers exposed to p-CNB during their jobs at a chemical enterprise in Shaoxing, Zhejiang Province, China were included in the exposure group, while administrative personnel who do not come into contact with p-CNB at work were included in the control group. Each worker in the exposure group was equipped with a personal air sampler to collect airborne p-CNB samples, and urine samples were collected at the conclusion of each shift. After sample collection, the airborne p-CNB concentrations and urinary metabolite concentrations were detected by gas chromatography-tandem mass spectrometry and ultra-performance liquid chromatography - quadrupole - orbitrap high resolution mass spectrometry, respectively. The urinary metabolite concentrations were corrected by the content of urinary creatinine. Subsequently, the correlations between the urinary metabolite concentrations and the p-CNB time-weighted average (TWA) concentrations were assessed using correlation analysis. All p-CNB TWA concentrations measured in this study were below the occupational exposure limit in the Chinese national standards. In the exposure group, N-acetyl-S-(4-nitrophenyl)-L-cysteine (NANPC), 2-chloro-5-nitrophenol (2C5NP), p-chloroacetanilide (p-CAA), p-chlorooxanilic acid (p-COA), 2-amino-5-chlorophenol (2A5CP), and p-chloroaniline (p-CA) were detected at varying levels. The percentages of NANPC, 2C5NP, p - CAA, p - COA, 2A5CP, and p - CA were 64.1%, 5.1%, 0.3%, 15.1%, 5.1%, and 10.3%, respectively. We found extremely significant positive relationships (p < 0.01) between the urinary metabolite concentrations (p-CA, 2C5NP, 2A5CP, NANPC, and p-COA) and the p-CNB TWA concentrations, with respective correlation coefficients of 0.827, 0.673, 0.790, 0.714, and 0.741. Thus, these five metabolites may be used as exposure biomarkers of occupational p-CNB exposure. Moreover, among these metabolites, NANPC was identified as the most suitable exposure biomarker because it had the highest correlation coefficient and the highest content in urine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.